You are here: Industry Insights > COVID-19

News List

GSK, Vir Biotech to test COVID-19 antibody treatment expresspharma
September 02, 2020
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation.
67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData expresspharma
September 02, 2020
Majority of respondents also consider the cost of decentralised clinical trials to be lower than that of traditional trials.
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment worldpharmanews
September 01, 2020
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced that the first patient was dosed last week in a phase 2/3 study with VIR-7831 (also known as GSK4182136), a fully human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) ...
BeiGene, Singlomics sign licencing agreement on neutralising Covid-19 antibodies pharmaceutical-business-review
September 01, 2020
BeiGene has entered into an exclusive licence agreement with Singlomics (Beijing DanXu) Biopharmaceuticals for neutralising Covid-19 antibodies.
FDA Broadens EUA for Remdesivir for COVID-19 americanpharmaceuticalreview
September 01, 2020
The U.S. Food and Drug Administration (FDA) has broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or ...
FDA grants EUA for Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
September 01, 2020
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Gilead Sciences’ Veklury (remdesivir) to treat all hospitalised patients with Covid-19.
Novavax to Supply 76M Doses of COVID-19 Vax to Canada contractpharma
September 01, 2020
Pending finalized advance purchase agreement, Novavax will supply doses of NVX-CoV2373 beginning as early as 2Q21.
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials contractpharma
September 01, 2020
SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication.
Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products prnewswire
August 31, 2020
Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated to viral transport media (VTM) production.
Abbott's fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization worldpharmanews
August 31, 2020
Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW? COVID-19 Ag Card rapid test for detection of COVID-19 infection.